IHH Healthcare Berhad Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Prem Kumar Nair

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	2.1yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	2.1yrs
Yönetim Kurulu ortalama görev süresi	2.7yrs

Son yönetim güncellemeleri

Recent updates

CEO

Prem Kumar Nair (64 yo)

2.1yrs

Görev süresi

Dr. Prem Kumar Nair serves as Non-Executive Director of Parkway Trust Management Limited a Manager of Parkway Life Real Estate Investment Trust since November 17, 2023. He serves as Vice Chairman of the Bo...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Prem Kumar Nair	Group Chief Executive Officer	2.1yrs	Veri yok	Veri yok
Dilip Kadambi	Group Chief Financial Officer	1.6yrs	Veri yok	Veri yok
Ida binti Ab Rahim	Group General Counsel	6.4yrs	Veri yok	Veri yok
Sook Yean Foo	Group Chief Human Resource Officer	less than a year	Veri yok	Veri yok
Nili Shayrina Saat	Group Chief Risk Officer	less than a year	Veri yok	Veri yok
Stephen Byrne	Group Chief Internal Audit Officer	4.8yrs	Veri yok	Veri yok
Ashok Pandit	Group Chief Corporate Officer	4.3yrs	Veri yok	Veri yok
Chorng Ann Chow	Chief Executive Officer of IHH Healthcare Singapore	2.1yrs	Veri yok	Veri yok
Kenneth Tsang	Regional Chief Executive Officer of IHH Healthcare North Asia	no data	Veri yok	Veri yok
Hsiu Lim	Group Chief Medical Officer	4.2yrs	Veri yok	Veri yok
Kamal Amzan	Acting Chief Executive Officer of IHH Healthcare Malaysia	less than a year	Veri yok	Veri yok
Ching Seow	Company Secretary	13.7yrs	Veri yok	Veri yok

2.1yrs

Ortalama Görev Süresi

51.5yo

Ortalama Yaş

Deneyimli Yönetim: Q0F 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.1 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yoichiro Endo	Non-Independent Non-Executive Director	1.6yrs	RM 277.00k	Veri yok
Nik Norzrul Bin Nik Hassan Thani	Independent Non-Executive Chairman	1.4yrs	RM 361.00k	Veri yok
Muthanna Bin Abdullah	Independent Non-Executive Director	4.8yrs	RM 689.00k	Veri yok
Satoshi Tanaka	Independent Non-Executive Director	4.8yrs	RM 514.00k	Veri yok
Mehmet Aydinlar	Non-Independent Non-Executive Director	13.8yrs	RM 404.00k	0.17% SGD 38.8m
Jill Watts	Independent Non-Executive Director	7.6yrs	RM 689.00k	Veri yok
Mohd Bin Mohd Harris	Non-Independent Non-Executive Director	2.7yrs	RM 380.00k	Veri yok
Tomo Nagahiro	Non-Independent Non-Executive Director	2.8yrs	RM 404.00k	Veri yok
Jia Mok	Non Independent & Non Executive Alternate Director	2.8yrs	Veri yok	Veri yok
Wah Yeow Tan	Independent & Non Executive Director	less than a year	Veri yok	Veri yok
Bin Chua	Independent Non Executive Director	1.3yrs	RM 263.00k	Veri yok
Shahida binti Mohd Jaffar Sadiq Maricar	Non Independent & Non Executive Director	less than a year	Veri yok	Veri yok

2.7yrs

Ortalama Görev Süresi

64.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: Q0F 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.7 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/11/28 19:30
Gün Sonu Hisse Fiyatı	2025/11/28 00:00
Kazançlar	2025/09/30
Yıllık Kazançlar	2024/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

IHH Healthcare Berhad 32 Bu analistlerden 21, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Ken-Wern Lim	Affin Hwang Investment Bank
Khir Goh	AmInvestment Bank Berhad
null null	BIMB Securities Sdn. Bhd

IHH Healthcare Berhad Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

IHH Healthcare Berhad Appoints Tomo Nagahiro as Member of Nomination and Remuneration Committee, Effective 26 November 2025

Ihh Healthcare Berhad Appoints Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee, Date of Change Is 25 September 2025

IHH Healthcare Berhad, Annual General Meeting, May 28, 2025

High number of new directors

IHH Healthcare Berhad Announces Appointment of Li Shuling, Christine as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

Recent updates

Third quarter 2025 earnings released: EPS: RM0.07 (vs RM0.061 in 3Q 2024)

IHH Healthcare Berhad Appoints Tomo Nagahiro as Member of Nomination and Remuneration Committee, Effective 26 November 2025

Now 22% undervalued

Now 21% undervalued

Now 22% undervalued

Ihh Healthcare Berhad Appoints Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee, Date of Change Is 25 September 2025

Upcoming dividend of RM0.05 per share

Second quarter 2025 earnings released: EPS: RM0.05 (vs RM0.071 in 2Q 2024)

IHH Healthcare Berhad Announces Interim Single Tier Cash Dividend for the Financial Year Ending 31 December 2025, Payable on 30 October 2025

First quarter 2025 earnings released: EPS: RM0.058 (vs RM0.087 in 1Q 2024)

IHH Healthcare Berhad Provides Group Revenue Guidance for the Year 2025

IHH Healthcare Berhad to Report Q1, 2025 Results on May 29, 2025

IHH Healthcare Berhad, Annual General Meeting, May 28, 2025

High number of new directors

Upcoming dividend of RM0.055 per share

IHH Healthcare Berhad Announces Appointment of Li Shuling, Christine as Non Independent and Non Executive Alternate Director

Final dividend of RM0.055 announced

Full year 2024 earnings released: EPS: RM0.30 (vs RM0.34 in FY 2023)

New major risk - Revenue and earnings growth

IHH Healthcare Berhad to Report Q4, 2024 Results on Feb 27, 2025

Third quarter 2024 earnings released: EPS: RM0.061 (vs RM0.06 in 3Q 2023)

IHH Healthcare Berhad to Report Q3, 2024 Results on Nov 28, 2024

Upcoming dividend of RM0.045 per share

First half dividend of RM0.045 announced

IHH Healthcare Berhad Declares Interim Single Tier Cash Dividend for the Financial Year Ending 31 December 2024, Payable on October 30, 2024

Second quarter 2024 earnings released: EPS: RM0.071 (vs RM0.034 in 2Q 2023)

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces the Appointment of Chua Bin Hwee as Independent and Non Executive Director, Effective August 14, 2024

IHH Healthcare Berhad to Report Q2, 2024 Results on Aug 30, 2024

IHH Healthcare Berhad Appoints Tan Sri Dr. Nik Norzrul Thani Bin N. Hassan Thani as Independent and Non Executive Chairman

New minor risk - Earnings quality

First quarter 2024 earnings released: EPS: RM0.087 (vs RM0.16 in 1Q 2023)

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

IHH Healthcare Berhad to Report Q1, 2024 Results on May 29, 2024

High number of new directors

IHH Healthcare Berhad, Annual General Meeting, May 28, 2024

IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer

Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024

Upcoming dividend of RM0.055 per share

Dividend of RM0.055 announced

Full year 2023 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad to Report Q4, 2023 Results on Feb 29, 2024

IHH Healthcare Berhad Announces Cessation of Joerg Ayrle as Chief Financial Officer

Third quarter 2023 earnings released: EPS: RM0.06 (vs RM0.028 in 3Q 2022)

IHH Healthcare Berhad to Report Q3, 2023 Results on Nov 30, 2023

IHH Healthcare Berhad Announces Joerg Ayrle, Group Chief Financial Officer to Remain on Garden Leave, Effective from 30 September 2023

Upcoming dividend of RM0.035 per share at 1.2% yield

IHH Healthcare Berhad Appoints Prem Kumar Nair as Group Chief Executive Officer, Effective from October 1, 2023

IHH Healthcare Berhad Declares Interim Dividend, Payable on October 27, 2023

Second quarter 2023 earnings released: EPS: RM0.034 (vs RM0.067 in 2Q 2022)

IHH Healthcare Berhad to Report Q2, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: RM0.16 (vs RM0.054 in 1Q 2022)

Upcoming dividend of RM0.096 per share at 1.2% yield

IHH Healthcare Berhad to Report Q1, 2023 Results on May 31, 2023

IHH Healthcare Berhad Announces Special Cash Dividend, Payable on 30 June 2023

High number of new directors

Upcoming dividend of RM0.07 per share at 1.2% yield

Full year 2022 earnings released: EPS: RM0.17 (vs RM0.20 in FY 2021)

IHH Healthcare Berhad Announces Appointment of Mr. Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces Resignation of Farid Bin Mohamed Sani as Non Independent and Non Executive Director

IHH Healthcare Berhad Appoints Tomo Nagahiro as Non-Independent and Non-Executive Director

IHH Healthcare Berhad to Report Q4, 2022 Results on Feb 28, 2023

IHH Healthcare Berhad Announces the Resignation of Tomo Nagahiro as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad Announces the Cessation of Takeshi Saito as Member of Nomination and Remuneration Committee, Effective January 27, 2023

Third quarter 2022 earnings released: EPS: RM0.028 (vs RM0.06 in 3Q 2021)

IHH Healthcare Berhad to Report Q3, 2022 Results on Nov 29, 2022

United States Federal District Court Grants IHH Healthcare Berhad Motion to Dismiss Emqore Amended Complaint

Second quarter 2022 earnings released: EPS: RM0.067 (vs RM0.053 in 2Q 2021)